Literature DB >> 8106422

An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes.

K Kariya1, L R Karns, P C Simpson.   

Abstract

In hypertrophy of cultured rat cardiac myocytes, alpha 1-adrenergic agonists activate protein kinase C (PKC) and up-regulate beta-myosin heavy chain (MHC). The 3300-base pair (bp) rat beta-MHC promoter is stimulated by both an alpha 1-agonist and a constitutively activated mutant of beta-PKC (Kariya, K., Karns, L. R., Simpson, P. C. (1991) J. Biol. Chem. 266, 10023-10026). Here, we report the convergence of alpha 1-adrenergic and beta-PKC signaling on the same element of the beta-MHC promoter. A 20-bp sequence in the beta-MHC promoter (-215/-196) was required for induction by both alpha 1-adrenergic stimulation and beta-PKC and conferred induction on a heterologous promoter. This sequence bound myocyte nuclear factor(s) through a 9-bp "enhancer core" (5'-TGTGGTATG-3'). A 3-bp mutation within the enhancer core which abolished factor binding also abolished inducibility of a 215-bp beta-MHC promoter. These results support the idea that beta-PKC is in the pathway for alpha 1-adrenergic regulation of beta-MHC transcription during cardiac myocyte hypertrophy. The enhancer core is the first PKC response element mapped by transfection of an activated PKC mutant, rather than by treatment with phorbol esters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106422

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload.

Authors:  R von Harsdorf; J G Edwards; Y T Shen; R K Kudej; R Dietz; L A Leinwand; B Nadal-Ginard; S F Vatner
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation.

Authors:  Y Xia; L M Buja; R C Scarpulla; J B McMillin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.

Authors:  Naohiro Yamaguchi; Asima Chakraborty; Daniel A Pasek; Jeffery D Molkentin; Gerhard Meissner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

4.  Flanking sequences modulate the cell specificity of M-CAT elements.

Authors:  S B Larkin; I K Farrance; C P Ordahl
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Catecholamines and cardiac growth.

Authors:  M P Gupta; M Gupta; S Jakovcic; R Zak
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

6.  Restoration of the transient outward potassium current by noradrenaline in chagasic canine epicardium.

Authors:  W Han; S C Barr; L M Pacioretty; R F Gilmour
Journal:  J Physiol       Date:  1997-04-01       Impact factor: 5.182

7.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

8.  Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism.

Authors:  F Liang; D G Gardner
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

9.  Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes.

Authors:  M A Bogoyevitch; A Clerk; P H Sugden
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 10.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.